Skip to main content
Michael P. Teske
( out of 354 reviews )

Michael P. Teske, MD

Languages spoken: English

Clinical Locations

John A. Moran Eye Center

Salt Lake City
801-581-2352

Midvalley Health Center

Murray
801-585-3937
  • Michael P. Teske is the Director of Vitreoretinal Diseases and Surgery. Dr. Teske specializes in medical and surgical diseases of the retina and vitreous. His primary surgical interests include retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, retinopathy of prematurity, epiretinal membranes, macular holes and posterior segment trauma.

    Board Certification

    American Board of Ophthalmology
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 354 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    June 28, 2024
    MORAN EYE CENTER

    Dr. is a very skilled and knowledgeable physician. I am pleased to have as my physician.

    June 24, 2024
    MORAN EYE CENTER

    He did not make me feel like a new patient. He was warm, friendly, and took the time to explain everything.

    June 21, 2024
    MORAN EYE CENTER

    Excelente médico. Atento, muy profesional y explica muy bien, al paciente.

    June 20, 2024
    MORAN EYE CENTER

    As I understand it, I have a problem with the retina in my left eye. The problem sometimes requires a periodic injection every visit or so. I feel sure that if I did not receive very good treatment that it could result in severe problems -- perhaps complete loss of vision in that eye. So I want Dr. Teske and other physicians, other patients and staff to know how much I deeply appreciate Dr. Teske and other doctors, staff and the public to know how much I sincerely appreciate Dr. Teske, his staff and others to know how much I truly value their care.

    June 14, 2024
    MORAN EYE CENTER

    Inspires trust and confidence.

    June 14, 2024
    MORAN EYE CENTER

    Wonderful Doctor who explains treatment needed for my successful outcome.

    June 08, 2024
    MORAN EYE CENTER

    Dr. Teske listens carefully and offers insight, responds to questions clearly, and overall creates confidence in his treatment.

    June 07, 2024
    MORAN EYE CENTER

    Professional ,thorough and caring

    June 06, 2024
    MORAN EYE CENTER

    An excellent dr. Great bedside skills

  • Michael P. Teske is the Director of Vitreoretinal Diseases and Surgery. Dr. Teske specializes in medical and surgical diseases of the retina and vitreous. His primary surgical interests include retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, retinopathy of prematurity, epiretinal membranes, macular holes and posterior segment trauma.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Board Certification
    American Board of Ophthalmology
    National Board of Medical Examiners

    Education history

    Fellowship Retina/Vitreous - Wayne State University, Kresge Eye Institute Fellow
    Ophthalmology - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Medicine - University of California - Los Angeles M.D.
    Undergraduate University of Notre Dame B.S.

    Selected Publications

    Journal Article

    1. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NK, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (08/01/2018). Effect of Oral Valproic Acid vs. Placdbo for Vision Loss in Paients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856.
    2. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NL, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (2018). Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856. (Read full article)
    3. Bell JE, Shulman JP, Swan RJ, Teske MP, Bernstein PS (2017). Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage. Ophthalmic Surg Lasers Imaging Retina, 48(1), 26-32. (Read full article)